Skip to content
Home/Companies/Pharma/SERB
SERB

SERB

Pharma·Belgium·Active·9yr hold
Entry
2017
Hold
9yr
Status
Active

Who owns SERB?

SERB is a Belgian Pharma company, currently owned by Charterhouse Capital Partners since 2017.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Charterhouse Capital Partners
Investor
Charterhouse Capital Partners
Charterhouse Capital Partners X · 2016 · Buyout

Key facts

SectorPharma
Websiteserb.com

More from Charterhouse Capital Partners X

Other portfolio companies in the same fund.

Labelium
Active
IT ServicesFrance· 2021
Funecap Groupe
Funecap Groupe
Active
Business ServicesFrance· 2018
SIACI Saint-Honore
Exited 2021
FinancialsFrance· 2018
to Ontario Teachers Pension Plan and Burrus Group
SLR Consulting
4.0xExited 2022
Business ServicesUK· 2018
to Ares Management
Casa Optima
Casa Optima
Exited 2025
ConsumerItaly· 2016
to Terlos
Sagemcom
Sagemcom
Active
TMTFrance· 2016

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns SERB?

SERB is currently owned by Charterhouse Capital Partners, through Charterhouse Capital Partners X, since 2017.

When did Charterhouse Capital Partners acquire SERB?

Charterhouse Capital Partners acquired SERB in 2017.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue